[PDF][PDF] T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation

H Feng, DL Stachura, RM White, A Gutierrez, L Zhang… - Cancer cell, 2010 - cell.com
H Feng, DL Stachura, RM White, A Gutierrez, L Zhang, T Sanda, CA Jette, JR Testa
Cancer cell, 2010cell.com
The molecular events underlying the progression of T-lymphoblastic lymphoma (T-LBL) to
acute T-lymphoblastic leukemia (T-ALL) remain elusive. In our zebrafish model, concomitant
overexpression of bcl-2 with Myc accelerated T-LBL onset while inhibiting progression to T-
ALL. The T-LBL cells failed to invade the vasculature and showed evidence of increased
homotypic cell-cell adhesion and autophagy. Further analysis using clinical biopsy
specimens revealed autophagy and increased levels of BCL2, S1P1, and ICAM1 in human …
Summary
The molecular events underlying the progression of T-lymphoblastic lymphoma (T-LBL) to acute T-lymphoblastic leukemia (T-ALL) remain elusive. In our zebrafish model, concomitant overexpression of bcl-2 with Myc accelerated T-LBL onset while inhibiting progression to T-ALL. The T-LBL cells failed to invade the vasculature and showed evidence of increased homotypic cell-cell adhesion and autophagy. Further analysis using clinical biopsy specimens revealed autophagy and increased levels of BCL2, S1P1, and ICAM1 in human T-LBL compared with T-ALL. Inhibition of S1P1 signaling in T-LBL cells led to decreased homotypic adhesion in vitro and increased tumor cell intravasation in vivo. Thus, blockade of intravasation and hematologic dissemination in T-LBL is due to elevated S1P1 signaling, increased expression of ICAM1, and augmented homotypic cell-cell adhesion.
cell.com